Cubist Systematic Strategies, LLC Pulmonx Corp Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $368,962 - $627,939	63,945 Added 141.6%	109,105 $691,000
Q1 2024 May 15, 2024	BUY	$8.71 - $14.65 $393,343 - $661,594	45,160 New	45,160 $418,000
Q1 2023 May 15, 2023	SELL	$7.49 - $12.54 $234,084 - $391,912	-31,253 Reduced 95.68%	1,410 $15,000
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $2,273 - $8,015	462 Added 1.43%	32,663 $275,000
Q3 2022 Nov 14, 2022	SELL	$15.35 - $23.99 $1.46 Million - $2.28 Million	-95,130 Reduced 74.71%	32,201 $536,000
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $1.68 Million - $3.35 Million	119,973 Added 1630.51%	127,331 $1.87 Million
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $519,734 - $876,883	-24,597 Reduced 76.97%	7,358 $183,000
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $225,010 - $341,452	7,571 Added 31.05%	31,955 $1.03 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $482,275 - $596,209	13,404 Added 122.08%	24,384 $877,000
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $412,957 - $527,040	10,980 New	10,980 $484,000
Q1 2021 May 17, 2021	SELL	$44.0 - $67.54 $34,188 - $52,478	-777 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $30,543 - $53,628	777 New	777 $54,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.